𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis

✍ Scribed by IAN B. TURNER; MARGARET MYSZOR; HARRIET C. MITCHISON; MARK K. BENNETT; ALISTAIR D. BURT; OLIVER F. W. JAMES


Book ID
118704359
Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
639 KB
Volume
9
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A randomized, double-blind, placebo-cont
✍ Burton Combes; Robert L. Carithers Jr.; Willis C. Maddrey; Danyu Lin; Dr Mary F. πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 792 KB

One hundred fifty-one patients with primary biliary cirrhosis (PBC) grouped into four strata based on entry serum bilirubin (<2 mg/dL vs. 2 mg/dL or greater) and liver histology (stages I, 1 1 vs. stages 111, IV-Ludwig criteria) were randomized within each stratum to ursodiol or placebo given in a s

The canadian multicenter double-blind ra
✍ E. Jenny Heathcote; Karen Cauch-Dudek; Valery Walker; Robert J. Bailey; Laurence πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 969 KB

Ursodeoxycholic acid, a dihydroxyl bile acid normally present in human beings in minimal amounts, becomes incorporated into the bile salt pool when taken orally. In cholestasis, bile acids are retained in the liver and are hepatotoxic. Ursodeoxycholic acid is the least-known hepatotoxic bile acid, h